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Abstract: In this paper, we describe our all-titanium microelectrode array (tMEA) 
fabrication process and show that uncoated titanium microelectrodes are fully applicable to 
measuring field potentials (FPs) from neurons and cardiomyocytes. Many novel research 
questions require custom designed microelectrode configurations different from the few 
commercially available ones. As several different configurations may be needed especially 
in a prototyping phase, considerable time and cost savings in MEA fabrication can be 
achieved by omitting the additional low impedance microelectrode coating, usually made 
of titanium nitride (TiN) or platinum black, and have a simplified and easily processable 
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MEA structure instead. Noise, impedance, and atomic force microscopy (AFM) 
characterization were performed to our uncoated titanium microelectrodes and commercial 
TiN coated microelectrodes and were supplemented by FP measurements from neurons and 
cardiomyocytes on both platforms. Despite the increased noise levels compared to 
commercial MEAs our tMEAs produced good FP measurements from neurons and 
cardiomyocytes. Thus, tMEAs offer a cost effective platform to develop custom designed 
electrode configurations and more complex monitoring environments. 
Keywords: microelectrode array (MEA); measurement noise; impedance; stem cell; field 
potential measurement; titanium 
 
1. Introduction 
In this paper, we introduce a relatively inexpensive method to fabricate custom microelectrode 
arrays (MEAs). Since the early 1970s, MEAs have been used [1], now for almost four decades, as 
powerful tools to measure field potentials (FPs) from various kinds of tissues and cell cultures, 
including neurons and cardiomyocytes. With MEAs it is possible to study the electrical activity on cell 
population level instead of single cells measured using patch clamp analysis. 
MEA platforms have been widely used in neuroscience research. Acute tissue slices, primary cells 
as well as cell lines can be cultured on different types of MEAs and their neuronal electrical activities 
can be measured [2-5]. MEAs offer useful, non-invasive, repeatable, and long term setups for neuronal 
network activity measurements that can be used to study spontaneous activity, effects of electrical and 
chemical stimuli, and plasticity [6-9]. Additionally, they can be used for drug screening purposes and 
for toxicological studies [10,11]. Nevertheless, only a few MEA studies have been conducted with 
human-derived neurons. Especially for drug screening or tissue engineering purposes, the use of 
human-derived neurons [6,12] would be important.  
MEAs serve also as a valuable tool in studying the basic electrophysiology of cardiomyocytes [13]. 
MEAs have been used in conduction studies of cardiomyocytes derived from human embryonic stem 
cells (hESCs) [14], for analyzing cardiomyocytes derived from different hESC lines [15] and for 
studying in vitro pharmacology of the hESC-derived cardiomyocytes [15-18]. The field potential 
duration (FPD) on MEAs has been shown to correspond to the QT prolongation potential of different 
drugs indicating that the platform may be useful in safety assays [19]. 
Most of the current in vitro research can well be performed using the commercially available 
MEAs. Novel research questions including controlled growth of cell networks, complex and sensor 
controlled cell culturing environments for long term measurements, or just new material trials are, 
however, constantly increasing demand for custom designed MEAs. Especially the prototyping phase 
of new ideas would benefit from MEA platforms enabling fast and low cost customization. 
When fabrication costs of a set of MEAs with several custom designed electrode configurations is 
considered, there are practically two ways to cut the costs. The first one is cutting the lithography mask 
costs, which can be achieved for example by reducing the area of the microlithographically patterned 
part [20,21], direct writing the custom patterns [22], or utilizing inexpensive film masks, which have 
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been applied, even though not discussed, also in this paper. Another way to cut the fabrication costs 
and also time, is to keep the MEA structure as simple as possible. It is clear that substrate, metal layer 
including electrodes, contact pads, and tracks, and an insulator layer are needed. The necessity of one 
more common part in the MEA structure, the additional microelectrode coating, however, can be 
questioned. 
Throughout MEA history, engineers have tried to improve the measurement and stimulation 
capabilities of the microelectrodes by applying an additional coating on a microelectrode base 
material. The coating is usually aimed to reduce noise and improve the impedance characteristics and 
charge transfer capacity of the microelectrodes, which affect the probability of detecting cellular activity 
and the stimulation capability. Wide availability and sufficiently good electrical characteristics have made 
platinum black (Pt black) probably the most commonly used microelectrode surface coating throughout 
MEA history [1,4,23,24], even if it suffers from adhesion and reproducibility problems [25,26]. TiN is the 
microelectrode surface material favored by one of the leading commercial MEA manufacturers (Multi 
Channel Systems (MCS), Reutlingen, Germany) [27-29]. Iridium oxide (IrOx) is widely studied, even 
though not yet commercialized, microelectrode coating that has excellent charge transfer capacity and 
high long term stability, but suffers from need for electrochemical (re)activation [25,26,30]. There is no 
common opinion whether TiN or IrOx has better characteristics [26,28,31]. Recently several groups 
have reported microelectrodes coated with carbon nanotubes (CNTs) [32-35] which have not only 
superior electrical properties but also support cell adhesion via extremely rough surface [34]. There 
are, however, general concerns related to the biocompatibility [36] and mechanical stability [26,35] of 
the CNT coatings. Expensive materials and in some cases necessary special devices and special 
expertise for reactive or otherwise complex processes make the additional coating often the most 
expensive, time consuming, and error prone phase in the MEA fabrication—an issue which can be 
ignored at most by very experienced and well equipped organizations. Thus if the sufficient MEA 
performance level can be reached without the additional coating, it may lead to significant cost and 
time savings in MEA fabrication. 
MEAs with gold, platinum, or indium tin oxide (ITO) microelectrodes without additional coating 
are commercially available [20], but certain aspects, e.g., material costs and processing difficulties, 
make those materials less attractive for simple and low cost fabrication schemes. Titanium, on the 
other hand, is a common, easy to process, and highly biocompatible electrode material. Titanium has 
not, however, been employed as sole MEA microelectrode material, but always either only as thin 
adhesion layer for some other metal [2,3,24,30] or coated with titanium nitride (TiN) [27]. The 
rationale against using titanium microelectrodes without additional coating may be the existence of a 
few nanometers thick dielectric native oxide (TiO2) layer which always forms on a titanium surface  
in air. However, direct tunneling through the thin dielectric layer [37], existence of conducting  
suboxides [37-39], and impurities originating from the glass surface prior to titanium deposition [38] 
have been proposed to account for local electron transfer through the native oxide layer, thus giving 
rise to sufficient conductivity.  
The aim of this study is to show that the FP measurement capabilities of titanium microelectrodes 
without any additional surface coating are well comparable to standard microelectrodes used today. As 
shown in this paper, with our in-house MEAs (later referred to as tMEAs), such microelectrodes are 
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fully capable for FP measurements from neurons and cardiomyocytes, yielding signal quality well 
sufficient for the intended analysis purposes.  
2. Methods 
2.1. tMEA Fabrication 
Our in-house built tMEAs have 58 microelectrodes in 8 × 8 square matrix format, with one 
microelectrode missing from each corner and two microelectrodes missing from both sides close to the 
central line. There are two large electrodes on both sides of the matrix which can be used as 
measurement reference, ground, and stimulation electrodes. In the first batch of tMEAs (later referred 
to as old tMEAs, because of being used in biological measurements before noise and impedance 
measurements), all the microelectrodes were square shaped and approximately 30 × 30 µm in size. The 
second batch of tMEAs (later referred to as new tMEAs, because not used in biological measurements 
before other measurements) suffered from certain processing condition failures causing microelectrode 
size variation and rounding of the intended square shape with the average microelectrode diameter of 
23 µm. To verify noise performance vs. electrode area dependence, some of the microelectrodes were 
made larger (55 µm in diameter). The inter-electrode distance was 200 µm in all tMEAs. 
The fabrication process of tMEAs is illustrated in Figure 1. Briefly, a 0.9 mm thick Schott Desag 
D263 glass (Schott, Mainz, Germany) was chosen for the substrate material due to its high mechanical 
durability. The glass was cut into 49 × 49 mm size wafers, cleaned with dishwashing liquid, water and 
ethanol, and e-beam coated with 300 nm layer of titanium at Oplatek Oy (Leppävirta, Finland). Before 
proceeding to the next lithographic steps, the glass wafers were cleaned with acetone, 2-propanol, and 
de-ionized water. Spin coated hexamethyldisilazane (HMDS, Acros Organics, Geel, Belgium) was 
used as photoresist adhesion promoter followed with immediate spin coating of ma-P 1225 positive 
photoresist (micro resist technology, Berlin, Germany) to ~2.2 µm thickness that was further baked on 
the wafers. Next, the microelectrode pattern from laser photoplotted mask was UV-exposed, developed, 
and hardbaked on photoresist. 
Figure 1. Fabrication process of tMEAs: (a) Bulk glass wafer; (b) Titanium coating; 
(c) Photoresist coating; (d) UV-exposure and development; (e) Wet etching and resist 
removal; (f) PECVD deposition of Si3N4; (g) Photoresist coating; (h) UV-exposure and 
development; and (i) Dry etching and resist removal. Images are not to scale. 
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Wet etching (20 H2O:1 H2O2 (30%):1 HF) was used to transfer the microelectrode pattern from the 
photoresist layer to titanium. After cleaning the wafer from remaining photoresist, a 500 nm layer of 
silicon nitride (Si3N4) was PECVD deposited as dielectric insulating layer at Optoelectronics Research 
Centre (ORC, Tampere University of Technology, Tampere, Finland). Lithographic steps for making 
openings for electrodes and contact pads in the insulator layer were performed with the same 
procedures as the patterning of titanium described above. After the hardbake step, however, reactive 
ion etching with SF6 and O2 gases [40] was applied instead of wet etching. In final fabrication step, a 
short oxygen plasma treatment (O2 30 sccm, RF power 30 W, pressure 30 mTorr), was run in reactive 
ion etcher (RIE, Advanced Vacuum Vision 320, Advanced Vacuum, Lomma, Sweden) to make the 
surface hydrophilic. 
2.2. Commercial MEAs Used for Comparison 
The commercial MEAs (later referred to as cMEAs) used in the study were standard MEAs of type 
200/30iR-Ti (MCS). The 59 round microelectrodes in 8 × 8 square format had the diameter of 30 µm 
and the inter-electrode distance of 200 µm. Titanium was used as a conductor base material and, unlike 
in tMEAs, both the electrodes and the contact pads were coated with TiN. Alike in tMEAs, 500 nm 
PECVD silicon nitride was used as an insulator layer [27] 
2.3. Noise Measurements 
Noise and biological FP measurements were performed with MEA1060-Inv-BC amplifier and 
MC_Rack software, both from MCS. The noise signal was recorded from MEAs filled with 
cardiomyocyte cell culture medium (EB-medium) without cells, at first for three minutes immediately 
after filling the MEAs, and after one and two hours to see how the noise behaves as a function of time. 
The measurement sampling frequency was 20 kHz. Total of three new and three old tMEAs and three 
new and three old cMEAs were measured. 
From each MEA, 6 microelectrodes from the second row were chosen for noise analysis. From the data, 
we calculated root mean square (RMS) noise for each microelectrode by using the following formula: 
∑
=
=
n
i
ixn
RMS
1
21  (1) 
where n is the number of samples in the measured signal and xi is the voltage sample measured at time i. 
For each MEA, an average RMS noise was calculated. Thereafter, average RMS noise for each MEA 
type was calculated from the average RMS noises of individual MEAs. As it has been shown that the 
noise of microelectrodes is inversely related to the square root of the electrode area [41], for fair 
comparisons between tMEAs and cMEAs, the RMS noise levels of tMEA microelectrodes were 
normalized to correspond to the RMS noise level of a microelectrode with the area equal to the area of 
a cMEA microelectrode. 
Noise voltage spectra over the frequency range from 0.3 Hz to 10 kHz were plotted using the Welch 
estimate method [42] with the 50% overlapping and window length of 60615 samples. Estimates were 
calculated with a Measurement Signal Processing (MSP) toolbox [43] for Matlab. Also noise voltage 
histograms with 200 bins of width 20 µV were calculated for the microelectrodes. 
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2.4. Impedance Measurements  
Impedances of the tMEA and cMEA microelectrodes were measured using Solartron Analytical 
1260A Impedance/Gain-phase Analyzer (Solartron Analytical, Hampshire, UK) connected to Solartron 
1294A Impedance Interface, whose four-terminal non-human interface was utilized, and connected 
according to the two-terminal impedance measurement configuration described in [44]. 1294A was 
connected to a MEA via MEA1060-Inv contacting adapter (MCS). The MEAs were let stabilize at 
least over night at room temperature in isotonic saline (sodium chloride 9 mg/mL, Baxter, Lessines, 
Belgium), rinsed with distilled water, and let stabilize for at least one hour filled with the cardiac cell 
culture medium (described in detail in Section 2.6) prior to impedance measurement. The contact pins 
of the contacting adapter and the MEA contact pads were cleaned with 70% ethanol. The temperature 
of a MEA was allowed to stabilize to approximately 37 °C for at least three minutes in the contacting 
adapter. Impedance measurement current was set to 10 μA. Current driven measurement setup was 
selected to ensure that the current density remained sufficiently low (approx. 14 mA/mm2 for a 
microelectrode diameter of 30 µm) regardless of microelectrode impedances.  
Impedances were measured at 1 kHz, which is the common practice also in commercial MEA 
datasheets, and data was recorded using SMaRT software (Solartron Analytical). With tMEAs, the 
ground electrode on the same side of the MEA as in the cMEAs was used. For fair comparison between 
tMEAs and cMEAs, the impedance magnitudes of the tMEA microelectrodes were normalized by the 
microelectrode surface areas so that all impedance magnitudes are presented for microelectrodes with the 
surface area of cMEA microelectrodes. In the sequel, this is referred to as area-normalization. 
As one potential source for lower impedance is the bigger effective surface area, we also performed 
atomic force microscopy (AFM) measurements (XE-100 AFM, Park Systems, Suwon, Korea) to assess 
effective surface area difference between titanium and TiN surfaces. For each MEA type 1 µm × 1 µm 
scans including 256 × 256 pixels were performed in a tapping mode. 
2.5. Assessment of Neuronal Cell FP Measurement Capabilities 
The neural differentiation of hESCs was performed as reported [45,46] and MEA preparation and 
measurements were performed as described earlier [6]. Prior to cell seeding, the MEAs were coated 
with two step coating procedure with 0.05%(w/v) polyethylenimine (PEI) and mouse laminin,  
20 µg/mL (both from Sigma-Aldrich, St. Louis, MO, USA). Thereafter, neurospheres, predifferentiated 
from hESCs for 8 weeks, were cut into small aggregates (∅ ~100 µm) and seeded onto coated MEA 
plates. Neuronal culture consisted of 1:1 DMEM/F12 and Neurobasal media supplemented with  
2 mM GlutaMax, 1 × B27, 1 × N2 (all from Invitrogen, Carlsbad, CA, USA), and 25 U/mL 
penicillin/streptomycin (Lonza, Basel, Switzerland). The medium was changed 3 times per week. The 
cells were cultured for 21 days in vitro (DIV) on three tMEAs and on three cMEAs. Spontaneous 
activities of neuronal networks were measured for five minutes once a week. Neuronal action potential 
spike detection was performed based on an amplitude threshold at five times the signal standard 
deviation from the mean of the signal. Also, phase contrast microscope images were taken weekly. 
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2.6. Assessment of Cardiomyocyte FP Measurement Capabilities 
Differentiation of hESC line H7 was performed as described earlier [47]. The MEAs were coated as 
follows: 30 minutes with fetal bovine serum (Gibco, Invitrogen) after which they were washed twice 
with sterile water and one hour with 0.1% gelatine type A (Sigma-Aldrich). After coating the MEAs, 
the spontaneously beating cardiomyocyte aggregates, excised from cell cultures mechanically, were 
plated onto the electrode areas in cell culture medium consisting of KO-DMEM (Invitrogen) supplemented 
with 20% FBS (Invitrogen), 1% NEAA (Lonza), 1% Glutamax (Invitrogen), and 50 U/mL 
penicillin/streptomycin (Lonza). The cells were cultured for 14 days in vitro on four tMEAs and on 
three cMEAs. After 14 days in culture on MEA, baseline electrical signal was recorded and the effect 
of E-4031 (Alomone Labs, Jerusalem, Israel), a known blocker of human ether-a-go-go potassium 
current at the concentration of 300 nM was analyzed in order to test whether tMEAs were sensitive 
enough to detect changes in the cardiac repolarization current.  
3. Results and Discussion 
3.1. tMEA Fabrication 
By omitting additional microelectrode coating we were able to save at least one deposition step 
compared to Pt black coated microelectrodes [24] and one deposition and one lift-off process step, 
compared to TiN coating [29]. Depending on the selected fabrication method, CNT and IrOx coatings 
might need even more process steps. Cutting process steps does not only save time and money, but 
decreases the risk of process failures and increases the repeatability of the fabrication process. In the 
case of integrating sensors or cell growth guiding structures on MEAs or replacing chemically  
and thermally durable glass substrate or silicon nitride insulator layer by some polymer based  
materials [48,49], each additional process step might be even fatal for the most sensitive layers or force 
to make unpractical changes in the fabrication process chain.  
3.2. Noise Analysis  
Even if precise statistical analysis was omitted due to difficulty of defining the exact area of each 
individual arbitrary shaped microelectrode, a rough comparison of RMS noise levels between the 
normal approximately 23 µm microelectrodes and 55 µm control microelectrodes of new tMEAs 
allowed us to conclude that at least on average, the tMEAs follow the theory of the noise of electrodes 
being inversely related to the square root of the electrode area [41]. Thus, we were able to normalize 
the RMS noise data of tMEAs to correspond the electrode size of cMEAs, i.e., 30 µm in diameter.  
The average measured RMS noises both from three new and three old tMEAs and cMEAs with 
average deviations along with the area normalized average RMS noises of tMEAs are all shown in 
Table 1. The results indicate roughly 33% higher noise for the new tMEAs compared to new cMEAs 
and roughly 90% higher noise for the old tMEAs compared to old cMEAs. The lower noise of old 
MEAs compared to new MEAs is probably mainly due to electrode surface modifications caused by 
long term exposure to cell and culture medium. At least for tMEAs, but possibly also for cMEAs, the 
batch to batch variations partly explain the noise variations. The uncontrolled long term natural 
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oxidation of titanium may partly explain the ten times larger deviation in average RMS noise from 
MEA to MEA observed in tMEAs compared to cMEAs. Another explanation for the larger deviation is 
tMEAs’ presumably bigger deviation also on microelectrode sizes and other MEA structure 
dimensions compared to cMEAs. 
Table 1. Average RMS noise and impedance magnitudes (area-normalized) comparison of 
three new (unused) and three old (previously used in biological measurements) tMEAs and 
cMEAs at three different times after filling the MEAs with medium.  
Time 
(h) 
Average 
measured 
RMS 
noise 
(µV) 
Average  
noise 
deviation 
(µV) 
Average 
normalized 
RMS noise 
(µV) 
Average 
normalized 
impedance 
magnitude 
at 1 kHz 
(kΩ) 
Average 
normalized 
impedance 
magnitude 
deviation 
(kΩ) 
 Average 
measured 
RMS 
noise 
(µV) 
Average 
noise 
deviation 
(µV) 
Average 
normalized 
impedance 
magnitude 
at 1 kHz 
(kΩ) 
Average 
normalized 
impedance 
magnitude 
deviation 
(kΩ) 
 New tMEA  New cMEA 
0 8.3 3.7 7.5 - -  5.7 0.3 - - 
1 7.1 1.1 6.4 126.6 39.1  4.9 0.3 54.8 1.0 
2 7.1 2.1 6.3 - -  4.7 0.3 - - 
 Old tMEA  Old cMEA 
0 5.1 1.6 5.8 - -  2.7 0.2 - - 
1 4.3 2.7 4.8 68.0 20.4  2.7 0.1 42.5 2.5 
2 4.3 1.7 4.8 - -  2.7 0.1 - - 
Figure 2. (a) Typical noise voltage density spectra of old tMEA and cMEA 
microelectrodes at times of 0 h, 1 h, and 2 h after filling the MEAs with medium. Noise 
voltage histograms (200 bins of width 0.2 µV) at the time of 1 h time point are presented 
from the same (b) tMEA and (c) cMEA microelectrodes. 
 
(a) 
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Figure 2. Cont.  
 
(b)     (c) 
Typical noise voltage spectra are shown in [Figure 2(a)] from one microelectrode of an old tMEA 
and an old cMEA 0, 1, and 2 h after filling the MEAs with medium. [Figure 2(b,c)] include  
200 bin noise voltage histograms from the same microelectrodes at the 1 h time point. Both MEA 
types have quite constant spectrum behavior as a function of time over the full frequency range 
excluding the clear drop at very low frequency between 0 h and 1 h in tMEA’s spectrum. At about 
2,640 Hz, both MEA types exhibit a peak, which we assume to originate from the amplifier 
electronics. In general some microelectrodes of some MEAs of all types also exhibited other 
occasional peaks, induced by some random additional activity in the laboratory or some MEA or 
microelectrode specific defects. Observable of 50 Hz mains frequency peak was more common in 
tMEAs than cMEAs. The shape of the histograms resembles in both cases Gaussian, but as can be 
assumed, the distribution for the tMEAs is wider. 
3.3. Impedance Magnitude Analysis 
Average impedances measured at 1 kHz and normalized by the microelectrode area relative to that 
of the cMEA electrodes are given in Table 1 in conjunction with the corresponding average RMS noise 
values. The impedances of the tMEAs are on the average 60% higher for old MEAs and 130% higher 
for new MEAs than those of the corresponding cMEAs.  
The impedance magnitude values measured for cMEAs are at the same level with the earlier 
reported values [27-29]. As no previous reports about titanium MEAs exist, there is no direct 
comparison to earlier results corresponding to tMEAs. However one order of magnitude difference in 
impedance has been reported for uncoated and TiN coated gold microelectrodes [28,29], and Pt and ITO 
microelectrodes of the corresponding size have been reported having impedances above 800 kΩ [20]. 
Even if different studies are not fully comparable due to obvious differences in impedance 
measurement arrangements and microelectrode sizes, still the impedance characteristics of titanium 
microelectrodes can be considered competitive to other single material microelectrodes.Typical AFM 
images of the microelectrode surface of tMEA and cMEA are presented in Figure 3. Due to the 
columnar morphology of the TiN coating [27,28] the AFM cantilever is able to measure only the very 
top surface of the TiN coating, giving no more than 10% increase in the effective surface area 
compared to the uncoated titanium. Thus, we suspect that our AFM has failed to convey full information 
of the fine surface structures, resulting in underestimating the effective surface area difference between 
tMEAs and cMEAs. The differences in noise and impedance values between tMEAs and cMEAs result 
from differences in effective surface areas due to different surface microstructures, and from different 
surface electrochemistries, including the natural oxidation of titanium.  
Micromachines 2011, 2 403 
 
 
Figure 3. AFM images from (a) all-titanium microelectrode of tMEA and (b) TiN coated 
microelectrode surface of cMEA. Note the different vertical z-axis scales. 
 
3.4. Viability and Electrical Signaling of Neurons on tMEAs 
The neuronal aggregates attached successfully to all MEAs [Figure 4(a,c)]. The viability of the cells 
was similar on both tMEAs and cMEAs. Neurons started to grow processes and some cells migrated 
along these processes. In more detail, neuronal cells formed neural networks on tMEA surface and the 
spontaneous activity of the networks was measured with titanium microelectrodes [Figure 4(b)]. 
Corresponding spontaneous activity observed with cMEAs is presented in [Figure 4(d)]. Similarly, 
during the first week of culturing on MEA, the first individual spikes were detected on both MEA 
types. Further, the signaling developed as shown earlier [6] into more organized train-like activity 
[Figure 4(b,d)] and even burst activity. tMEAs had twice as high noise levels as the cMEAs, but the 
spikes were twice as high too. Thus tMEAs showed signal-to-noise (S/N) ratio comparable to cMEAs. 
The results support all-titanium MEAs’ capability to function as an efficient and tunable tool for 
measuring neuronal activity and maturation with different electrode layouts. 
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from DIV 4 onward, which was the first day of recording. The signal amplitude grew larger over time 
reaching the peak value at DIV 7. The morphology of the signal was also better defined by that time, 
marked by a higher S/N ratio, which was a direct result of the larger systolic peak amplitude. This 
indicated stronger cell adhesion of the cardiomyocytes to the MEAs and better and more mature 
connection between cells. tMEAs tended to have greater variation in background noise levels between 
recordings of the same MEA than cMEAs. Also, a cardiac drug effect could be adequately and 
repeatedly recorded with tMEA. The hERG channel blocker E-4031, known to prolong QT time and 
FPD, prolonged FPD approximately 50% [Figure 4(f)]. All this indicates as a proof-of-concept that  
all-titanium MEAs can be used for drug testing and that the resolution of the signal generated is good 
enough to detect changes in FP morphology. 
4. Conclusions  
Our experiments with hESC-derived neurons and cardiomyocytes show that the performance of  
all-titanium MEA microelectrodes is comparable to MEAs with TiN coated microelectrodes when the 
recording of FP signals from neuronal cells or cardiomyocytes is considered. For certain type of 
applications requiring detection of very weak signals or exact signal morphology, all-titanium MEA, 
despite its comparable S/N ratio, may not be the optimal choice because of higher background noise 
and fluctuations. Furthermore, as the impedance measurement indicates, also the charge transfer 
capacity of titanium electrodes may have to be improved by some additional electrode surface coating 
for stimulation purposes, especially for cardiac cells—even though this was not fully evaluated in this 
paper. However, for many applications such as neuronal or cardiac activity, maturation, or drug testing 
where small additional noise is not an issue, the performance of all-titanium MEAs is adequate to 
detect neuronal spiking or changes in the cardiomyocyte FP morphology. The all-titanium technology 
presents us with several advantages in terms of modifying the MEA platform for future uses. These 
include being able to design and manufacture a variety of MEA layouts and microelectrode 
configurations in a cost and time effective manner e.g., for more complex experimental setups of 
neuronal network geometries or cardiomyocyte syncytium and connectivity studies.  
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